Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
InMed Pharmaceuticals Inc
INM
Healthcare
Cannabis
InMed Pharmaceuticals Inc. is a pharmaceutical company. It develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharmaceuticals segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare...
cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is cannabinoid analog being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a cannabinol topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:INM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(30)
•••
Stevemin
X
View Profile
View Bullboard History
Comment by
Stevemin
on Feb 10, 2022 5:31pm
RE:InMed Earnings 10 Feb 2022
Inmed IR has all but said not to expect any insight on the retail numbers. I have a sneaky suspicion that they dont give any hard numbers at all and blame it on the fact that they have been too busy
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 10, 2022 12:45pm
Radical Clinical Trial - Rare Cannabinoids
https://www.benzinga.com/node/25535334
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Comment by
Bullknit101
on Feb 10, 2022 12:43pm
RE:InMed Earnings 10 Feb 2022
According to the NASDAQ website, the 10 Feb release date was based on an algorithm. Earnings released is on actually on 15 Feb 2022. https://financialpost.com/globe-newswire/inmed-pharmaceuticals-to
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 09, 2022 5:41pm
InMed Earnings 10 Feb 2022
Looking for first ever revenue numbers. Prolly around $200-$300k for the quarter. https://www.nasdaq.com/market-activity/stocks/inm/earnings?random=6204106e960ed
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 09, 2022 5:20pm
InMed Earnings 10 Feb 2022
Looking for first ever revenue numbers. Prolly around $200-$300k for the quarter. https://www.nasdaq.com/market-activity/stocks/inm/earnings?random=6204106e960ed
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 06, 2022 8:55am
SynBio Industry Challenges 2021
https://seekingalpha.com/article/4484181-amyris-surviving-perfect-storm
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 04, 2022 6:09am
Cannabinoid Market
https://youtu.be/T8W72-JPYrs
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 02, 2022 7:17pm
THCV Cannabinoid
InMed has started commercial scale production of THCV, in addition to CBC and CBT. https://www.metrotimes.com/detroit/the-new-frontier-of-cannabinoids-research-thcv-shown-to-give-users-hyper-focus
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 01, 2022 3:33pm
Cannabinoid Manufacturing
https://www.cbdwire.com/inmed-pharmaceuticals-inc-s-nasdaq-inm-recent-access-of-manufacturing-technologies-now-give-it-the-potential-to-synthetically-produce-rare-cannabinoids-at-large-scale-a-unique
...more
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jan 28, 2022 6:27pm
Edison Heath Care Update
https://youtu.be/5TcnIxGBSCU
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jan 26, 2022 11:03pm
Big Pharma Interest in CBDV
CBDV is currently being scaled up by InMed and should be available soon now that CBT has been launched. https://www.laweekly.com/all-about-cbdv-effects-benefits-best-strains/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jan 24, 2022 4:16pm
InMed Dales Discussion
https://m.youtube.com/watch?v=8lGuAgazbhs&t=870s&pp=2AHmBpACAQ%3D%3D
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jan 23, 2022 9:18am
Cannabinoids for Dementia
https://www.express.co.uk/life-style/health/1553852/cannabis-medicinal-benefits-dementia
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jan 22, 2022 11:36am
CBC Cannabinoid for ARDS
https://pubmed.ncbi.nlm.nih.gov/34598736/
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Jan 22, 2022 8:21am
InMed Q2 Earnings
The upcoming Q2 Earnings Report on 10 Feb will show initial sales revenues. I expect at least between $300k-$600k from CBC sales to start. CBT sales will be reflected next quarterly and then I would
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >